Advancing hair loss research
Not an actual patient
clinical trials
The first Phase 3 trials for an oral therapy in nearly 30 years.
Veradermics is currently pursuing three multi-center, randomized, double-blind, placebo-controlled studies evaluating the safety and efficacy of VDPHL01, the potential first oral non-hormonal FDA-approved therapy for pattern hair loss, in both men and women.
Our clinical program includes:
Large, randomized
Phase 3 trials
With aim to study 1500 men and women with pattern hair loss.
Dedicated studies for
both men and women
First ever Phase 3 trial for female pattern hair loss.
Not an actual patient
Rigorous clinical
endpoints
Focused on measuring visible pattern hair loss.
clinical trials underway
Now enrolling females
with pattern hair loss
We are currently enrolling female participants in the first Phase 2/3 national clinical trial for women with pattern hair loss to evaluate our lead product candidate, VDPHL01, the potential first-ever, extended-release, oral minoxidil for pattern hair loss.
For more information and to see if you qualify:
